Global IBS-C Drugs Market Insights, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
| Report ID : 202376 | No. of Pages : 180
The research team projects that the IBS-C Drugs market size will grow from XXX in 2021 to XXX by 2028, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2021 to 2028.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
By Type
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
By Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of IBS-C Drugs 2015-2020, and development forecast 2021-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the IBS-C Drugs Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the IBS-C Drugs Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the IBS-C Drugs market in 2020.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Table of Contents
1 Industry Overview
1.1 IBS-C Drugs Industry
Figure IBS-C Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of IBS-C Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of IBS-C Drugs
1.2.2 Downstream
Table Application Segment of IBS-C Drugs
Table Global IBS-C Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 IBS-C Drugs Market by Type
3.1 By Type
3.1.1 Linaclotide
Table Major Company List of Linaclotide
3.1.2 Lubiprostone
Table Major Company List of Lubiprostone
3.1.3 Osmotic Laxatives
Table Major Company List of Osmotic Laxatives
3.1.4 Stimulant Laxatives
Table Major Company List of Stimulant Laxatives
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global IBS-C Drugs Market 2016-2020, by Type, in USD Million
Figure Global IBS-C Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global IBS-C Drugs Market 2016-2020, by Type, in Volume
Figure Global IBS-C Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Catalent Pharmaceuticals Solutions (Company Profile, Sales Data etc.)
4.1.1 Catalent Pharmaceuticals Solutions Profile
Table Catalent Pharmaceuticals Solutions Overview List
4.1.2 Catalent Pharmaceuticals Solutions Products & Services
4.1.3 Catalent Pharmaceuticals Solutions Business Operation Conditions
Table Business Operation of Catalent Pharmaceuticals Solutions (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Nestle (Company Profile, Sales Data etc.)
4.2.1 Nestle Profile
Table Nestle Overview List
4.2.2 Nestle Products & Services
4.2.3 Nestle Business Operation Conditions
Table Business Operation of Nestle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Abbott Laboratories (Company Profile, Sales Data etc.)
4.3.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
4.3.2 Abbott Laboratories Products & Services
4.3.3 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Synergy Pharmaceuticals (Company Profile, Sales Data etc.)
4.4.1 Synergy Pharmaceuticals Profile
Table Synergy Pharmaceuticals Overview List
4.4.2 Synergy Pharmaceuticals Products & Services
4.4.3 Synergy Pharmaceuticals Business Operation Conditions
Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
4.5.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
4.5.2 Sucampo Pharmaceuticals Products & Services
4.5.3 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis Pharma Ag (Company Profile, Sales Data etc.)
4.6.1 Novartis Pharma Ag Profile
Table Novartis Pharma Ag Overview List
4.6.2 Novartis Pharma Ag Products & Services
4.6.3 Novartis Pharma Ag Business Operation Conditions
Table Business Operation of Novartis Pharma Ag (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Astellas Pharmaceuticals (Company Profile, Sales Data etc.)
4.7.1 Astellas Pharmaceuticals Profile
Table Astellas Pharmaceuticals Overview List
4.7.2 Astellas Pharmaceuticals Products & Services
4.7.3 Astellas Pharmaceuticals Business Operation Conditions
Table Business Operation of Astellas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Ardelyx, Inc (Company Profile, Sales Data etc.)
4.8.1 Ardelyx, Inc Profile
Table Ardelyx, Inc Overview List
4.8.2 Ardelyx, Inc Products & Services
4.8.3 Ardelyx, Inc Business Operation Conditions
Table Business Operation of Ardelyx, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Synthetic Biologics, Inc (Company Profile, Sales Data etc.)
4.9.1 Synthetic Biologics, Inc Profile
Table Synthetic Biologics, Inc Overview List
4.9.2 Synthetic Biologics, Inc Products & Services
4.9.3 Synthetic Biologics, Inc Business Operation Conditions
Table Business Operation of Synthetic Biologics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva Pharmaceutical Industries (Company Profile, Sales Data etc.)
4.10.1 Teva Pharmaceutical Industries Profile
Table Teva Pharmaceutical Industries Overview List
4.10.2 Teva Pharmaceutical Industries Products & Services
4.10.3 Teva Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Bama-Geve, SLU (Company Profile, Sales Data etc.)
4.11.1 Bama-Geve, SLU Profile
Table Bama-Geve, SLU Overview List
4.11.2 Bama-Geve, SLU Products & Services
4.11.3 Bama-Geve, SLU Business Operation Conditions
Table Business Operation of Bama-Geve, SLU (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Ferring BV (Company Profile, Sales Data etc.)
4.12.1 Ferring BV Profile
Table Ferring BV Overview List
4.12.2 Ferring BV Products & Services
4.12.3 Ferring BV Business Operation Conditions
Table Business Operation of Ferring BV (Sales Revenue, Cost, Gross Margin)
4.13 Ironwood Pharmaceuticals, Inc (Company Profile, Sales Data etc.)
4.13.1 Ironwood Pharmaceuticals, Inc Profile
Table Ironwood Pharmaceuticals, Inc Overview List
4.13.2 Ironwood Pharmaceuticals, Inc Products & Services
4.13.3 Ironwood Pharmaceuticals, Inc Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Salix Pharmaceuticals Ltd (Company Profile, Sales Data etc.)
4.14.1 Salix Pharmaceuticals Ltd Profile
Table Salix Pharmaceuticals Ltd Overview List
4.14.2 Salix Pharmaceuticals Ltd Products & Services
4.14.3 Salix Pharmaceuticals Ltd Business Operation Conditions
Table Business Operation of Salix Pharmaceuticals Ltd (Sales Revenue, Cost, Gross Margin)
4.15 Norgine B.V (Company Profile, Sales Data etc.)
4.15.1 Norgine B.V Profile
Table Norgine B.V Overview List
4.15.2 Norgine B.V Products & Services
4.15.3 Norgine B.V Business Operation Conditions
Table Business Operation of Norgine B.V (Sales Revenue, Cost, Gross Margin)
4.16 Prometheus Laboratories Inc (Company Profile, Sales Data etc.)
4.16.1 Prometheus Laboratories Inc Profile
Table Prometheus Laboratories Inc Overview List
4.16.2 Prometheus Laboratories Inc Products & Services
4.16.3 Prometheus Laboratories Inc Business Operation Conditions
Table Business Operation of Prometheus Laboratories Inc (Sales Revenue, Cost, Gross Margin)
4.17 Actavis Nordic A/S (Company Profile, Sales Data etc.)
4.17.1 Actavis Nordic A/S Profile
Table Actavis Nordic A/S Overview List
4.17.2 Actavis Nordic A/S Products & Services
4.17.3 Actavis Nordic A/S Business Operation Conditions
Table Business Operation of Actavis Nordic A/S (Sales Revenue, Cost, Gross Margin)
4.18 Albireo Pharma Inc (Company Profile, Sales Data etc.)
4.18.1 Albireo Pharma Inc Profile
Table Albireo Pharma Inc Overview List
4.18.2 Albireo Pharma Inc Products & Services
4.18.3 Albireo Pharma Inc Business Operation Conditions
Table Business Operation of Albireo Pharma Inc (Sales Revenue, Cost, Gross Margin)
4.19 Yuhan Corp (Company Profile, Sales Data etc.)
4.19.1 Yuhan Corp Profile
Table Yuhan Corp Overview List
4.19.2 Yuhan Corp Products & Services
4.19.3 Yuhan Corp Business Operation Conditions
Table Business Operation of Yuhan Corp (Sales Revenue, Cost, Gross Margin)
4.20 Astrazeneca Plc (Company Profile, Sales Data etc.)
4.20.1 Astrazeneca Plc Profile
Table Astrazeneca Plc Overview List
4.20.2 Astrazeneca Plc Products & Services
4.20.3 Astrazeneca Plc Business Operation Conditions
Table Business Operation of Astrazeneca Plc (Sales Revenue, Cost, Gross Margin)
4.21 The Menarini Group (Company Profile, Sales Data etc.)
4.21.1 The Menarini Group Profile
Table The Menarini Group Overview List
4.21.2 The Menarini Group Products & Services
4.21.3 The Menarini Group Business Operation Conditions
Table Business Operation of The Menarini Group (Sales Revenue, Cost, Gross Margin)
4.22 Ono Pharmaceutical Co., Ltd (Company Profile, Sales Data etc.)
4.22.1 Ono Pharmaceutical Co., Ltd Profile
Table Ono Pharmaceutical Co., Ltd Overview List
4.22.2 Ono Pharmaceutical Co., Ltd Products & Services
4.22.3 Ono Pharmaceutical Co., Ltd Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global IBS-C Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global IBS-C Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global IBS-C Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global IBS-C Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global IBS-C Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global IBS-C Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America IBS-C Drugs Market Concentration, in 2020
Figure Europe IBS-C Drugs Market Market Concentration, in 2020
Figure Asia-Pacific IBS-C Drugs MMarket Concentration, in 2020
Figure South America IBS-C Drugs Market Concentration, in 2020
Figure Middle East & Africa IBS-C Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
Figure IBS-C Drugs Demand in Hospital Pharmacies, 2016-2020, in USD Million
Figure IBS-C Drugs Demand in Hospital Pharmacies, 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacies
Figure IBS-C Drugs Demand in Retail Pharmacies, 2016-2020, in USD Million
Figure IBS-C Drugs Demand in Retail Pharmacies, 2016-2020, in Volume
6.1.3 Demand in Online Pharmacies
Figure IBS-C Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
Figure IBS-C Drugs Demand in Online Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure IBS-C Drugs Market Growth 2021-2026, by Application, in USD Million
Figure IBS-C Drugs Market Share in 2026, by Application, in USD Million
Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in Volume
Table IBS-C Drugs Market Growth 2021-2026, by Application, in Volume
Table IBS-C Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table IBS-C Drugs Production 2016-2020, by Region, in USD Million
Table IBS-C Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global IBS-C Drugs Market 2016-2020, by Region, in USD Million
Table Global IBS-C Drugs Market Share 2016-2020, by Region, in USD Million
Table Global IBS-C Drugs Market 2016-2020, by Region, in Volume
Table Global IBS-C Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table North America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table South America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table IBS-C Drugs Market Forecast 2021-2026, by Region, in USD Million
Table IBS-C Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of IBS-C Drugs
2. Table Application Segment of IBS-C Drugs
3. Table Global IBS-C Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Lubiprostone
5. Table Major Company List of Osmotic Laxatives
6. Table Major Company List of Stimulant Laxatives
7. Table Major Company List of Others
8. Table Global IBS-C Drugs Market 2016-2020, by Type, in USD Million
9. Table Global IBS-C Drugs Market 2016-2020, by Type, in Volume
10. Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in USD Million
11. Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in Volume
12. Table Catalent Pharmaceuticals Solutions Overview List
13. Table Business Operation of Catalent Pharmaceuticals Solutions (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Nestle Overview List
15. Table Business Operation of Nestle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Abbott Laboratories Overview List
17. Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Synergy Pharmaceuticals Overview List
19. Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Sucampo Pharmaceuticals Overview List
21. Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Novartis Pharma Ag Overview List
23. Table Business Operation of Novartis Pharma Ag (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Astellas Pharmaceuticals Overview List
25. Table Business Operation of Astellas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Ardelyx, Inc Overview List
27. Table Business Operation of Ardelyx, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Synthetic Biologics, Inc Overview List
29. Table Business Operation of Synthetic Biologics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Teva Pharmaceutical Industries Overview List
31. Table Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Bama-Geve, SLU Overview List
33. Table Business Operation of Bama-Geve, SLU (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Ferring BV Overview List
35. Table Business Operation of Ferring BV (Sales Revenue, Cost, Gross Margin)
36. Table Ironwood Pharmaceuticals, Inc Overview List
37. Table Business Operation of Ironwood Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
38. Table Salix Pharmaceuticals Ltd Overview List
39. Table Business Operation of Salix Pharmaceuticals Ltd (Sales Revenue, Cost, Gross Margin)
40. Table Norgine B.V Overview List
41. Table Business Operation of Norgine B.V (Sales Revenue, Cost, Gross Margin)
42. Table Prometheus Laboratories Inc Overview List
43. Table Business Operation of Prometheus Laboratories Inc (Sales Revenue, Cost, Gross Margin)
44. Table Actavis Nordic A/S Overview List
45. Table Business Operation of Actavis Nordic A/S (Sales Revenue, Cost, Gross Margin)
46. Table Albireo Pharma Inc Overview List
47. Table Business Operation of Albireo Pharma Inc (Sales Revenue, Cost, Gross Margin)
48. Table Yuhan Corp Overview List
49. Table Business Operation of Yuhan Corp (Sales Revenue, Cost, Gross Margin)
50. Table Astrazeneca Plc Overview List
51. Table Business Operation of Astrazeneca Plc (Sales Revenue, Cost, Gross Margin)
52. Table The Menarini Group Overview List
53. Table Business Operation of The Menarini Group (Sales Revenue, Cost, Gross Margin)
54. Table Ono Pharmaceutical Co., Ltd Overview List
55. Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)
56. Table Global IBS-C Drugs Sales Revenue 2016-2020, by Company, in USD Million
57. Table Global IBS-C Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
58. Table Global IBS-C Drugs Sales Volume 2016-2020, by Company, in Volume
59. Table Global IBS-C Drugs Sales Volume Share 2016-2020, by Company, in Volume
60. Table Regional Demand Comparison List
61. Table Major Application in Different Regions
62. Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in USD Million
63. Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in Volume
64. Table IBS-C Drugs Market Growth 2021-2026, by Application, in Volume
65. Table IBS-C Drugs Market Share in 2026, by Application, in Volume
66. Table IBS-C Drugs Production 2016-2020, by Region, in USD Million
67. Table IBS-C Drugs Production 2016-2020, by Region, in Volume
68. Table Global IBS-C Drugs Market 2016-2020, by Region, in USD Million
69. Table Global IBS-C Drugs Market Share 2016-2020, by Region, in USD Million
70. Table Global IBS-C Drugs Market 2016-2020, by Region, in Volume
71. Table Global IBS-C Drugs Market Share 2016-2020, by Region, in Volume
72. Table North America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
73. Table North America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
74. Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
75. Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in Volume
76. Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
77. Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in Volume
78. Table South America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
79. Table South America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
80. Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
81. Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in Volume
82. Table IBS-C Drugs Market Forecast 2021-2026, by Region, in USD Million
83. Table IBS-C Drugs Market Forecast 2021-2026, by Region, in Volume
84. Table Price Factors List
List of Figure
List of Figure
1. Figure IBS-C Drugs Industry Chain Structure
2. Figure Global IBS-C Drugs Market Growth 2016-2020, by Type, in USD Million
3. Figure Global IBS-C Drugs Market Growth 2016-2020, by Type, in Volume
4. Figure Global IBS-C Drugs Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global IBS-C Drugs Sales Volume Share in 2020, by Company, in Volume
6. Figure North America IBS-C Drugs Market Concentration, in 2020
7. Figure Europe IBS-C Drugs Market Market Concentration, in 2020
8. Figure Asia-Pacific IBS-C Drugs MMarket Concentration, in 2020
9. Figure South America IBS-C Drugs Market Concentration, in 2020
10. Figure Middle East & Africa IBS-C Drugs Market Concentration, in 2020
11. Figure IBS-C Drugs Demand in Hospital Pharmacies, 2016-2020, in USD Million
12. Figure IBS-C Drugs Demand in Hospital Pharmacies, 2016-2020, in Volume
13. Figure IBS-C Drugs Demand in Retail Pharmacies, 2016-2020, in USD Million
14. Figure IBS-C Drugs Demand in Retail Pharmacies, 2016-2020, in Volume
15. Figure IBS-C Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
16. Figure IBS-C Drugs Demand in Online Pharmacies, 2016-2020, in Volume
17. Figure IBS-C Drugs Market Growth 2021-2026, by Application, in USD Million
18. Figure IBS-C Drugs Market Share in 2026, by Application, in USD Million
19. Figure North America IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
20. Figure North America IBS-C Drugs Market Size and Growth 2016-2020, in Volume
21. Figure Europe IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
22. Figure Europe IBS-C Drugs Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2016-2020, in Volume
25. Figure South America IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
26. Figure South America IBS-C Drugs Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview